Alzheimer's Disease
1,111
57
76
741
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
295 trials with published results (27%)
Research Maturity
741 completed trials (67% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.2%
135 terminated out of 1111 trials
84.6%
-1.9% vs benchmark
18%
195 trials in Phase 3/4
40%
295 of 741 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 741 completed trials
Clinical Trials (1111)
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia
The Underlying Neural Mechanism of TMS in Improving the Imbalance of "Microbiota-brain-gut Axis" in Alzheimer 's Disease Population
Multi-modal Neuroimaging in Alzheimer's Disease IMAP+
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
Wake Forest Alzheimer's Disease Clinical Core
Visuospatial Attention, Eye Movements and Instrumental Activities of Daily Living (IADLs) in Alzheimer's Disease
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease
Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis
A Study to Compare Two Different Sleep Tests in Participants With No Symptoms or Early Symptoms of Alzheimer's Disease
Art of Memory for Cognitive Enhancement in the Monza Brain Health Service
Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease
Lombard Cohort of Brain Health Services
WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCT
System-IGF-1 Pathway and Alzheimer's Disease